Supplemental material
Drug Delivery
Volume 25, 2018 - Issue 1
Related Research Data
Dissemination and growth of cancer cells in metastatic sites
Source:
Springer Science and Business Media LLC
Co-expression and clinical utility of Snail and N-cadherin in papillary thyroid carcinoma
Source:
Springer Nature
Epithelial–mesenchymal transition in cancer metastasis: Mechanisms, markers and strategies to overcome drug resistance in the clinic
Source:
Elsevier BV
Identification of a novel function of TWIST, a bHLH protein, in the development of acquired taxol resistance in human cancer cells
Source:
Springer Science and Business Media LLC
A long non-coding RNA point of view
Source:
Informa UK Limited
Improvement of chemosensitivity and inhibition of migration via targeting tumor epithelial-to-mesenchymal transition cells by ADH-1-modified liposomes
Source:
Taylor & Francis
Epithelial-Mesenchymal Transitions in Development and Disease
Source:
Elsevier BV
Twist Transcriptionally Up-regulates AKT2 in Breast Cancer Cells Leading to Increased Migration, Invasion, and Resistance to Paclitaxel
Source:
American Association for Cancer Research (AACR)
Epithelial-Mesenchymal Transitions in development and disease: old views and new perspectives
Source:
UPV/EHU Press
Involvement of CD147 in regulation of multidrug resistance to P-gp substrate drugs and in vitro invasion in breast cancer cells
Source:
Wiley-Blackwell
A long non-coding RNA point of view
Source:
Informa UK Limited
Improvement of chemosensitivity and inhibition of migration via targeting tumor epithelial-to-mesenchymal transition cells by ADH-1-modified liposomes
Source:
Taylor & Francis
Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes
Source:
Elsevier BV
Epithelial--mesenchymal and mesenchymal--epithelial transitions in carcinoma progression.
Source:
Wiley
Cadherin switching
Source:
The Company of Biologists
Twist1-Mediated Adriamycin-Induced Epithelial-Mesenchymal Transition Relates to Multidrug Resistance and Invasive Potential in Breast Cancer Cells
Source:
American Association for Cancer Research (AACR)
Targeting efficiency of RGD-modified nanocarriers with different ligand intervals in response to integrin αvβ3 clustering
Source:
Elsevier BV
The impact of a chlorotoxin-modified liposome system on receptor MMP-2 and the receptor-associated protein ClC-3
Source:
Elsevier BV
Liposomal Drug Formulations
Source:
Springer Science and Business Media LLC
Active targeting with particulate drug carriers in tumor therapy: fundamentals and recent progress
Source:
Elsevier BV
Dual targeting for metastatic breast cancer and tumor neovasculature by EphA2-mediated nanocarriers
Source:
Elsevier BV
Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease
Source:
American Society for Clinical Investigation
Critical role of N-cadherin in myofibroblast invasion and migration in vitro stimulated by colon-cancer-cell-derived TGF-β or wounding
Source:
The Company of Biologists
Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer
Source:
Springer Nature America, Inc
Targeting N-Cadherin Enhances Antitumor Activity of Cytotoxic Therapies in Melanoma Treatment
Source:
American Association for Cancer Research (AACR)
New Insights into the Epithelial-to-Mesenchymal Transition in Cancer
Source:
Elsevier BV
Novel peptide mimetic small molecules of the HAV motif in N-cadherin inhibit N-cadherin-mediated neurite outgrowth and cell adhesion
Source:
Elsevier BV
Linking provided by
